Abstract
In the 21st century, humans are in the battle against a deadly contagious disease COVID-19, first reported in Wuhan, China. Coronavirus disease, designated as COVID-19, is caused by SARS CoV-2 virus from the beta coronavirus family. Although there are no specific anti- viral drugs and vaccines against this pandemic disease, however, many medicines are being repurposed for COVID-19 management but have shown limited success. Traditional medicine systems, since ancient time, were used for their immense efficacy with minimal adverse effects compared to allopathic medicines. Thus, for COVID-19 management, researchers are focusing on traditional medicines from Ayurveda, Chinese medicine, Unani, Siddha, and Homeopathy as adjuvant therapy as per anecdotal data regarding their use in the treatment of infectious disease. In India, all the traditional medicine systems are under AYUSH ministry and government has been highlighting AYSUH medicines for improving immune system against COVID-19. In this review, the authors emphasize on the historical background of AYUSH medicines in the prevention and treatment of infectious diseases and the medicines recommended by the AYUSH ministry for combating COVID-19 as immunity boosters.
Keywords: COVID-19, AYUSH, traditional medicine, SARS CoV-2, ayurveda, homeopathy, siddha, unani.
Graphical Abstract
Current Traditional Medicine
Title:AYUSH Preparations as Immunity Booster in the Management of SARS - CoV-2: A Review
Volume: 7 Issue: 4
Author(s): Suneel Prajapati*, Mahima Sharma, Arun Kumar, Ashish Tripathi, GV Narasimha Kumar, Shilpi Singh, Monika Singh, Digvijay Verma and Pankaj Gupta
Affiliation:
- Central Forensic Science Laboratory, Krishna Complex, Kharadi, Pune, Maharashtra,India
Keywords: COVID-19, AYUSH, traditional medicine, SARS CoV-2, ayurveda, homeopathy, siddha, unani.
Abstract: In the 21st century, humans are in the battle against a deadly contagious disease COVID-19, first reported in Wuhan, China. Coronavirus disease, designated as COVID-19, is caused by SARS CoV-2 virus from the beta coronavirus family. Although there are no specific anti- viral drugs and vaccines against this pandemic disease, however, many medicines are being repurposed for COVID-19 management but have shown limited success. Traditional medicine systems, since ancient time, were used for their immense efficacy with minimal adverse effects compared to allopathic medicines. Thus, for COVID-19 management, researchers are focusing on traditional medicines from Ayurveda, Chinese medicine, Unani, Siddha, and Homeopathy as adjuvant therapy as per anecdotal data regarding their use in the treatment of infectious disease. In India, all the traditional medicine systems are under AYUSH ministry and government has been highlighting AYSUH medicines for improving immune system against COVID-19. In this review, the authors emphasize on the historical background of AYUSH medicines in the prevention and treatment of infectious diseases and the medicines recommended by the AYUSH ministry for combating COVID-19 as immunity boosters.
Export Options
About this article
Cite this article as:
Prajapati Suneel *, Sharma Mahima, Kumar Arun , Tripathi Ashish , Kumar Narasimha GV , Singh Shilpi , Singh Monika, Verma Digvijay and Gupta Pankaj , AYUSH Preparations as Immunity Booster in the Management of SARS - CoV-2: A Review, Current Traditional Medicine 2021; 7 (4) : e190122188623 . https://dx.doi.org/10.2174/2215083806999201202151923
DOI https://dx.doi.org/10.2174/2215083806999201202151923 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Improved Prediction of Lysine Acetylation by Support Vector Machines
Protein & Peptide Letters Research and Patents on Coronavirus and COVID-19: A Review
Recent Patents on Nanotechnology Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential
Current Stem Cell Research & Therapy An Insight into Pandemic COVID-19: Structure, Epidemiology and Therapeutics
Current Biotechnology Progress in Computational Approach to Drug Development Against SARS
Current Medicinal Chemistry The Potential Mechanism of N-acetylcysteine in Treating COVID-19
Current Pharmaceutical Biotechnology A Review on Coronavirus Disease- A Future Challenge for Mankind (Focusing on Indian Situation)
Coronaviruses Epidemiology, Evolution, Transmission, and Therapeutics of COVID-19 Outbreak: An Update on the Status
Coronaviruses A Study on E-Learning and Recommendation System
Recent Advances in Computer Science and Communications Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times
Current Cardiology Reviews Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design Immunity Modulators, Repurposed Drugs and Candidate Vaccines for COVID-19: A Review
Coronaviruses Could Targeting HMGB1 be Useful for the Clinical Management of COVID-19 Infection?
Combinatorial Chemistry & High Throughput Screening Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections
Current Medicinal Chemistry Molecular Dynamics Simulations of CYP2E1
Medicinal Chemistry Dual Modulators of Selected Plant Secondary Metabolites Targeting COVID-19 Main Protease and Interleukin-2: An <i>In-Silico</i> Approach based Novel Hypothesis
Coronaviruses Management of Idiopathic Intracranial Hypertension During the COVID-19 Pandemic
Reviews on Recent Clinical Trials Response of Feline Immunodeficiency Virus (FIV) to Tipranavir May Provide New Clues for Development of Broad-Based Inhibitors of Retroviral Proteases Acting on Drug-Resistant HIV-1
Current HIV Research Comprehensive Review on Epidemiology, Diagnosis and Auspicious Management of COVID 19
Coronaviruses Molecular Docking Demonstration of the Liquorice Chemical Molecules on the Protease and ACE2 of COVID-19 Virus
Current Enzyme Inhibition